Diabetes Disease

What is Diabetes?

Diabetes is a chronic health condition that affects how your body turns food into energy. It occurs when your blood glucose (blood sugar) is too high.

Types of Diabetes

1. Type 1 Diabetes

2. Type 2 Diabetes

3. Gestational Diabetes

Symptoms of Diabetes

Causes and Risk Factors

Management and Treatment

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Complications of Diabetes


References & Research

Historical Background

Diabetes has been known since antiquity -- the term "diabetes" was coined by the Greek physician Aretaeus of Cappadocia in the 2nd century AD. The distinction between type 1 and type 2 diabetes was established by Harold Himsworth in 1936. The discovery of insulin by Frederick Banting and Charles Best in 1921 at the University of Toronto remains one of the most transformative breakthroughs in medical history, earning the Nobel Prize in 1923.

Key Research Papers

  1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
  2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.
  3. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572.
  4. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes (EMPA-REG OUTCOME). N Engl J Med. 2015;373(22):2117-2128.
  5. Marso SP, Daniels GH, Poulter NR, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes (LEADER). N Engl J Med. 2016;375(4):311-322.
  6. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program). N Engl J Med. 2002;346(6):393-403.
  7. American Diabetes Association. Standards of Medical Care in Diabetes -- 2020. Diabetes Care. 2020;43(Suppl 1):S1-S212.
  8. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes (CANVAS Program). N Engl J Med. 2017;377(7):644-657.
  9. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance (Finnish Diabetes Prevention Study). N Engl J Med. 2001;344(18):1343-1350.
  10. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Diabetes Care. 2015;38(1):140-149.
  11. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies. Lancet. 2016;387(10027):1513-1530.
  12. Gerstein HC, Colhoun HM, Dagenais GR, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND). Lancet. 2019;394(10193):121-130.

Back to Top



Deep-Dive Articles

Type 1 vs Type 2 vs LADA & MODY

Autoimmune T1D, insulin-resistant T2D, slowly-progressing LADA, and monogenic MODY — how to tell them apart and why misdiagnosis is common in adults.

A1c, Fructosamine & Glycation

What HbA1c actually measures, when it lies (anemia, pregnancy, hemoglobinopathies), fructosamine as a 2-3 week alternative, and the glycation-marker landscape.

CGM & Time-in-Range

Time-in-range (70-180) as the modern gold standard, GMI vs A1c, ambulatory glucose profile interpretation, and which devices (Dexcom G7, Libre 3, Medtronic 780G).

Insulin Types & Dosing

Basal, bolus, pre-mixed, ultra-rapid; basal-bolus vs pump therapy; carb counting, correction factors, insulin-to-carb ratios, and the closed-loop pump systems.

Cardio-Renal Protection: SGLT2s & GLP-1s

EMPA-REG, DAPA-HF, CREDENCE, FLOW, LEADER, SELECT — why these drugs' benefits extend beyond glucose and have reshaped diabetes guidelines.

Remission & Reversal

DiRECT trial, Virta Health 2-year keto data, bariatric-surgery remission, early-intensive-insulin, time-restricted eating. When remission is realistic and how to hold it.

Complications: Eye, Kidney, Nerve

Annual dilated eye exam, UACR and eGFR, monofilament and vibration testing, autonomic neuropathy. Screening cadence, prevention, and the drugs that slow progression.

Hypoglycemia & Awareness

Recognizing lows, hypoglycemia unawareness, the rule of 15, glucagon (Baqsimi, Gvoke, Zegalogue), nocturnal lows, dead-in-bed syndrome, and awareness restoration.

Diabetic Foot Care & Ulcer Prevention

Monofilament testing, ABI screening, offloading, and when to refer to wound care.

Table of Contents


Research Papers

The following PubMed topic searches aggregate the current peer-reviewed literature. Each link opens a live PubMed query — results update as new studies are indexed.

Back to Table of Contents


Connections

Back to Table of Contents


Video Thumbnail

Diabetes: Pathophysiology, Signs/Symptoms, Labs, Treatment & more - Medical-Surgical | @LevelUpRN

Video Thumbnail

Diabetes Type 1 vs Type 2 Explained: Symptoms, Treatment, & Nursing Care | Mini Lesson Series

Video Thumbnail

Diabetes insipidus - causes, symptoms, diagnosis, treatment, pathology

Video Thumbnail

Doctor Explains Diabetes Signs and Symptoms (High Sugar)

Video Thumbnail

Diabetes mellitus (type 1, type 2) & diabetic ketoacidosis (DKA)

Video Thumbnail

Mayo Clinic Explains Diabetes

Video Thumbnail

Doctor explains Diabetic Kidney Disease | Causes, symptoms, treatment and prevention

Video Thumbnail

Diabetes Complications: Hypoglycemia, DKA, HHS - Medical-Surgical (Endocrine) | @LevelUpRN

Video Thumbnail

Type 2 Diabetes Signs & Symptoms (& Why They Occur) & Associated Conditions